Get hopeful about the return of the Lyme disease vaccine, Lymerix. With proven efficacy and significant effectiveness, this vaccine could make a big impact on reducing the prevalence of the illness.
Global pharmaceutical company Mallinckrodt takes significant step in reducing debt and addressing opioid crisis through Restructuring Support Agreement.
Incyte Corp exceeds expectations with strong Q2 results driven by high demand for Jakafi and Opzelura drugs. Positive forecast revision and stock rise.
The Delhi High Court has asked for the government's response on a pharmaceutical company's plea on the ban of FDC drugs. Glenmark Pharmaceuticals challenges the ban on manufacturing, selling, and distributing certain FDC drugs for human use. The ban was announced on June 2 due to no therapeutic justification and potential risks. The court will hear the matter on July 3.